BPA for welireg
Active Awarded Last action
- Contract number
- 36E79725A0023
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 64% complete
- IDV ceiling
- $72,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Merck Sharp & Dohme LLC on July 12, 2025, with a ceiling of $72.5 million for Welireg (belzutifan) pharmaceutical procurement, extending through July 11, 2027.
The BPA is established against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which provides a framework for federal agencies to order pharmaceutical products at pre-negotiated pricing. Welireg is indicated for renal cell carcinoma treatment and represents a specialty therapeutic product within the federal healthcare procurement portfolio. The BPA incorporates 2026 Public Law pricing update mechanisms to align pricing with statutory requirements. Performance occurs nationwide across federal healthcare system locations where the product is distributed and administered. The single-award vehicle carries no set-aside designation and reflects open competitive procurement. This BPA supersedes a prior $15 million Welireg agreement with the National Acquisition Center awarded in August 2022, indicating sustained federal demand for this specialty cancer therapeutic through the government's pharmaceutical procurement channels.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0023?
36E79725A0023 was awarded to Merck Sharp & Dohme LLC by National Acquisition Center (Headquarters) on July 12, 2025.
How much is contract 36E79725A0023 worth?
36E79725A0023's own ceiling is $72,500,000.
Who can order from contract 36E79725A0023?
36E79725A0023 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0023 under another contract?
Yes. 36E79725A0023 is a blanket purchase agreement under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0023 competed?
The extent of competition for 36E79725A0023 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV